Oral Concurrent Session 1 - Prematurity
Oral Concurrent Sessions
Briana Ferguson, BA, MS
University of Pennsylvania, Perelman School of Medicine
Philadelphia, PA, United States
Aaron Loder, BS
University of Pennsylvania, Perelman School of Medicine
Philadelphia, PA, United States
Lauren Anton, PhD
University of Pennsylvania, Perelman School of Medicine
Philadelphia, PA, United States
Kristin D. Gerson, MD, PhD
Assistant Professor of Obstetrics and Gynecology
Assistant Professor of Microbiology
Hospital of the University of Pennsylvania
Philadelphia, PA, United States
A Lactobacillus-deplete vaginal microbiota confers increased risk of preterm birth (PTB). Our group previously uncovered a role for vaginal polyamines in distinguishing individuals at greatest risk of PTB among those with similar microbiota-related risk. Putrescine is a polyamine primarily produced by anaerobes and abundant in a Lactobacillus-deplete microbiota. We have shown that vaginal metabolites, including select polyamines, can modify immune responses at the host-microbial interface. As immune perturbations can contribute to cervical remodeling preceding PTB, we hypothesized that putrescine promotes inflammation in the cervical epithelium as a mechanism underlying barrier disruption.
Study Design:
Ectocervical and endocervical epithelial cells were treated with putrescine (500-4000uM) for 24h. For microbial experiments, cells were treated with 107 CFUs Gardnerella vaginalis (GV), an anaerobe prevalent in a Lactobacillus-deplete microbiota, in the presence or absence of putrescine. Inflammatory cytokines IL-8 and IL-1β were measured in cell culture media by ELISA. One-way ANOVAs with Dunnet’s multiple comparisons tests were performed.
Results:
Putrescine has no effect on basal levels of IL-8 or IL-1β in ectocervical and endocervical cells (Fig. 1). Putrescine partially mitigates GV-induction of IL-8 in ectocervical and endocervical cells in a dose-dependent manner (Fig. 1A). Putrescine partially mitigates GV-induction of IL-1β in endocervical cells in a dose-dependent manner (Fig. 1B). While a similar trend was observed in ectocervical cells, putrescine did not significantly modify GV-induction of IL-1β (Fig. 1B).
Conclusion:
Contrary to our hypothesis, vaginal putrescine exerts an anti-inflammatory effect on the cervical epithelium. Our data suggest that this microbial metabolite may blunt host immune responses and promote tolerance of a Lactobacillus-deplete anaerobe-rich microbiota. The extent to which this molecular process may modify epithelial barrier stability, cervical remodeling, and PTB risk warrants future investigation. SMFM-AAOGF Award (KDG)